Multi-Targeting Intranasal Nanoformulation as a Therapeutic for Alzheimer’s Disease

Melatonin, insulin, and Δ9-tetrahydrocannabinol (THC) have been shown to reverse cognitive deficits and attenuate neuropathologies in transgenic mouse models of Alzheimer’s disease (AD) when used individually. Here, we evaluated the therapeutic properties of long-term intranasal treatment with a nov...

Descripción completa

Detalles Bibliográficos
Autores principales: Fihurka, Oksana, Wang, Yanhong, Hong, Yuzhu, Lin, Xiaoyang, Shen, Ning, Yang, Haiqiang, Brown, Breanna, Mommer, Marcus, Zieneldien, Tarek, Li, Yitong, Kim, Janice, Li, Minghua, Cai, Jianfeng, Zhou, Qingyu, Cao, Chuanhai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953380/
https://www.ncbi.nlm.nih.gov/pubmed/36830601
http://dx.doi.org/10.3390/biom13020232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953380/
https://www.ncbi.nlm.nih.gov/pubmed/36830601
http://dx.doi.org/10.3390/biom13020232

Ejemplares similares